Infection Control Today® Editorial Staff

April 30, 2026

A Kansas jury awarded $7.65 million in a fatal KU Medical infection case tied to contaminated heater-cooler devices, renewing attention on Mycobacterium chimaera risks, device disinfection failures, and patient safety in cardiac surgery.

April 07, 2026

The cohosts of Contagious Conversation speak with Tori Whitacre Martonicz, lead editor of Infection Control Today, about her presentation at the SoCal SPA Spring Conference, and how the conference speakers emphasized leadership beyond titles, urging SPD professionals to share knowledge, speak up, and turn everyday insights into safer patient care practices.

April 07, 2026

Childhood vaccination coverage is declining, with sharp drops in influenza uptake and widening disparities by race, income, and access. CDC data warn that these trends increase outbreak risk and underscore the urgent need for targeted vaccination efforts.

April 01, 2026

Phase 3b ENCORE data show ARIKAYCE improves symptoms and culture conversion in newly diagnosed MAC lung disease, supporting earlier use. Findings suggest potential to shift treatment earlier and improve outcomes in this difficult-to-treat infection.

February 19, 2026

Cepheid has been selected by the CDC as a national collaborator to accelerate rapid diagnostic development during public health emergencies. With early access to outbreak samples and genomic data, the company aims to shorten response timelines and strengthen U.S. pandemic preparedness through scalable, high accuracy PCR testing solutions.

February 18, 2026

At CROI 2026 in Denver, ViiV Healthcare unveiled new data on ultralong-acting HIV treatments, including first-in-human results for third-generation integrase inhibitor VH184 and early capsid inhibitor data. Updated prevention and real-world findings highlight progress toward 4-month dosing and expanded options across adult and pediatric populations.